In popular literature, accounts of how to
deal with prenatal screening and foetal anomaly scan information, and how to live with the difficult decisions based on that information are appearing (Slagboom 2011). For societal actors, enriching public debate may entail discussing concepts and accounts of living with or without impairments and assimilating genetic information about oneself or one’s offspring. These concepts change over time and instead of a ‘collective eugenics’, we might be able to discuss and produce new collective, yet varying images of ‘the good life’. Acknowledgement This research was performed as part of the project ‘Reshaping criteria for screening in the age of genomics’ from the research programme of the Centre for Society and Genomics, in collaboration with the Centre for Medical Systems
Biology. Both centres are Centres of Excellence of the Netherlands Genomics Epigenetics inhibitor Initiative. We gratefully acknowledge Linda Krijgsman for her research on the VU University clippings archives and assistance during the research project. We also kindly Selleck AZD1390 thank Julia Challinor for improving the English. Conflict of interest The authors declare that they have no conflict of interest. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction Lumacaftor datasheet in any medium, provided the original author(s) and source are credited.
References Borry P, Cornel MC, Howard HC (2010) Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J Comm Genet 2010:101–106CrossRef BOSK. Brief van mevr. KA Kruidenier-Bron, voorzitter BOSK aan de Staatssecretaris van Welzijn, Volksgezondheid en Cultuur, drs H.J. Simons [Letter from Mrs KA Kruidenier-Bron, chair BOSK, to the State Secretary of Welfare, Health Care and Culture, HJ Simons ] August 1992 Chiu RWK, Akolekar R, Zheng YWL et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J 342:c7401. doi:10.1136/bmj.c7401 CrossRef Committee Obstetrics [Commissie Verloskunde] (2003) Verloskundig Vademecum 2003 [Obstetric Vademecum 2003]. College voor Zorgverzekeringen, Diemen Committee of Ministers (1992) On genetic testing and screening for health care purposes. Recommendation. Council of Europe. No. R (92) 3. de Jong A, Dondorp WJ, de Die-Smulders CEM, Frints SGM, de Wert GMWR (2010) Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 18:272–277 de Wert GMWR, Engel GL (1988) Erfelijkheidsadvisering als instrument van bevolkingseugenetica? Enkele kanttekeningen bij de nota ‘Preventie aangeboren afwijkingen’ [Genetic counseling as instrument of population eugenics? Some remarks on the report ‘Prevention congenital anomalies’].